Search results for "Drug Safety"


 
Results 11 - 20 of about 31 for "Drug Safety".

Test yourself

Fingolimod is classified as a pregnancy category C drug, and thus its safety in human pregnancy is not clearly established. ... Key Point. Fingolimod is classified as a pregnancy category C drug (safety in human pregnancy not clearly established) and
February 2018

New grass allergy treatment, opioid overdose solution

with the drug are likely to outweigh its potential risks for each patient. ... Approved on the fast track as an orphan drug, safety and efficacy were evaluated in 4 clinical trials including 547 treated patients.
June 2014

Quality improvement

Yea-Jen Hsu, PhD, MHA, senior research associate. Jodi Segal, MD, MHP, co-director, Johns Hopkins Center for Drug Safety and Effectiveness; associate director, Center for Health Services and Outcomes Research.
May 2016

Recommended: Move hydrocodone combo products to schedule II

A labeling update and drug safety communication on low-molecular-weight heparin, including enoxaparin, regarding the risk of spinal column bleeding and subsequent paralysis after spinal injections, including epidural procedures and ... Safety and
January 2014

FDA update

The agency had previously warned that this dose of the anti-nausea drug should be avoided due to the risk of QT-interval prolongation, which can lead to torsades de pointes.
December 2012

FDA asks clinicians to limit prescriptions of acetaminophen

Rutgers University in Newark, N.J., and president of BLCMD Associates LLC in Chapel Hill, N.C., which offers consulting services in drug safety. ... Indeed, in the November 2011 Drug Safety, researchers published a study examining the prescription data
May 2014

FDA update

However, the FDA continues to believe that the cardiovascular benefits of statins outweigh these small increased risks, according to the agency's drug safety update.
March 2012

Expanded approval on rivaroxaban, reassurance on dabigatran

dose should exceed 16 mg, according to the agency's drug safety communication online. ... The FDA is continuing to evaluate multiple sources of data in the ongoing safety review of this issue but has not changed its recommendations regarding the drug.
January 2013

Drug safety

a study drug, one of them a first-ever prescription, between January 1998 and December 2001. ... Overall, 76.3% of patients in the study-drug group received a prescription for a benzodiazepine, 38.8% received a prescription for a ā€œZā€ drug, and 13.4%
April 2014

Warning on PPIs and C. diff, contraceptive pill mixup

A warning about drug interactions between boceprevir (Victrelis) and ritonavir-boosted HIV protease inhibitor drugs. ... However, the FDA continues to believe that the cardiovascular benefits of statins outweigh these small increased risks, according to
April 2012

Prev   1   2   3   Next